Rocket Pharmaceuticals
RCKT
RCKT
163 hedge funds and large institutions have $1.34B invested in Rocket Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 72 increasing their positions, 37 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 17
3% less funds holding
Funds holding: 168 → 163 (-5)
8% less capital invested
Capital invested by funds: $1.46B → $1.34B (-$123M)
Holders
163
Holding in Top 10
3
Calls
$3.81M
Puts
$664K
Top Buyers
| 1 | +$17.3M | |
| 2 | +$10.7M | |
| 3 | +$10.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.3M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$7.32M |
Top Sellers
| 1 | -$21.8M | |
| 2 | -$9.81M | |
| 3 | -$6M | |
| 4 |
TM
Tiger Management
New York
|
-$5.47M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$5.05M |